Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable 1-47 is one of the several germline gene segments encoding the variable domain of immunoglobulin lambda light chains. This region is critical for antigen recognition and diversity in antibodies produced by B cells. Immunoglobulins mediate the humoral phase of the immune response, with the variable region enabling specific binding to pathogens. The diversity of antibody specificity arises from the recombination and mutation of variable domains like IGLV1-47, which, alongside its associated heavy chain, forms the antigen recognition epitope. This gene is located on chromosome 22 and is typically expressed in blood microparticles derived from B cells. IGLV1-47 is chiefly a genetic segment for immunoglobulin variability, and not a conventional molecular target for drug therapeutics.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable 1-47 (IGLV1-47).